These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 27287018)

  • 1. Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.
    Correa BR; de Araujo PR; Qiao M; Burns SC; Chen C; Schlegel R; Agarwal S; Galante PA; Penalva LO
    Genome Biol; 2016 Jun; 17(1):125. PubMed ID: 27287018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SON drives oncogenic RNA splicing in glioblastoma by regulating PTBP1/PTBP2 switching and RBFOX2 activity.
    Kim JH; Jeong K; Li J; Murphy JM; Vukadin L; Stone JK; Richard A; Tran J; Gillespie GY; Flemington EK; Sobol RW; Lim SS; Ahn EE
    Nat Commun; 2021 Sep; 12(1):5551. PubMed ID: 34548489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.
    Binder ZA; Siu IM; Eberhart CG; Ap Rhys C; Bai RY; Staedtke V; Zhang H; Smoll NR; Piantadosi S; Piccirillo SG; Dimeco F; Weingart JD; Vescovi A; Olivi A; Riggins GJ; Gallia GL
    PLoS One; 2013; 8(10):e75945. PubMed ID: 24146797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
    Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
    Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of glioma based on prognostic alternative splicing.
    Li Y; Ren Z; Peng Y; Li K; Wang X; Huang G; Qi S; Liu Y
    BMC Med Genomics; 2019 Nov; 12(1):165. PubMed ID: 31729991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
    Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
    Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation.
    Kosti A; de Araujo PR; Li WQ; Guardia GDA; Chiou J; Yi C; Ray D; Meliso F; Li YM; Delambre T; Qiao M; Burns SS; Lorbeer FK; Georgi F; Flosbach M; Klinnert S; Jenseit A; Lei X; Sandoval CR; Ha K; Zheng H; Pandey R; Gruslova A; Gupta YK; Brenner A; Kokovay E; Hughes TR; Morris QD; Galante PAF; Tiziani S; Penalva LOF
    Genome Biol; 2020 Aug; 21(1):195. PubMed ID: 32762776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidation of the genetic and epigenetic landscape alterations in RNA binding proteins in glioblastoma.
    Bhargava S; Patil V; Mahalingam K; Somasundaram K
    Oncotarget; 2017 Mar; 8(10):16650-16668. PubMed ID: 28035070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB.
    Barbagallo D; Caponnetto A; Cirnigliaro M; Brex D; Barbagallo C; D'Angeli F; Morrone A; Caltabiano R; Barbagallo GM; Ragusa M; Di Pietro C; Hansen TB; Purrello M
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
    Huang QR; Li JW; Pan XB
    Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma.
    Fang R; Chen X; Zhang S; Shi H; Ye Y; Shi H; Zou Z; Li P; Guo Q; Ma L; He C; Huang S
    Nat Commun; 2021 Jan; 12(1):177. PubMed ID: 33420027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA.
    Nawaz Z; Patil V; Paul Y; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
    Mol Cancer; 2016 Nov; 15(1):74. PubMed ID: 27871300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
    Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma.
    Se YB; Kim SH; Kim JY; Kim JE; Dho YS; Kim JW; Kim YH; Woo HG; Kim SH; Kang SH; Kim HJ; Kim TM; Lee ST; Choi SH; Park SH; Kim IH; Kim DG; Park CK
    Cancer Res Treat; 2017 Apr; 49(2):387-398. PubMed ID: 27456940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma.
    Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W
    J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.
    Bui TT; Nitta RT; Kahn SA; Razavi SM; Agarwal M; Aujla P; Gholamin S; Recht L; Li G
    BMC Cancer; 2015 Apr; 15():225. PubMed ID: 25884624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteogenomics of glioblastoma associates molecular patterns with survival.
    Yanovich-Arad G; Ofek P; Yeini E; Mardamshina M; Danilevsky A; Shomron N; Grossman R; Satchi-Fainaro R; Geiger T
    Cell Rep; 2021 Mar; 34(9):108787. PubMed ID: 33657365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the Cover: Neutralization of terminal differentiation in gliomagenesis.
    Hu J; Ho AL; Yuan L; Hu B; Hua S; Hwang SS; Zhang J; Hu T; Zheng H; Gan B; Wu G; Wang YA; Chin L; DePinho RA
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14520-7. PubMed ID: 23918370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.